Stay Informed About New Multiple Sclerosis Meds

Kesimpta and Zeposia will add to the growing list of meds to treat relapsing-remitting multiple sclerosis (MS).

Patients with MS usually begin treatment right reduce flares and slow progression.

Most start with traditional injectables, such as Avonex (interferon beta) or Copaxone (glatiramer acetate).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote